Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ganser
Gary Ganser, Morgantown, WV US
| Patent application number | Description | Published |
|---|---|---|
| 20110247611 | APPARATUS AND METHOD FOR DELIVERY OF AN AEROSOL - An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants. | 10-13-2011 |
Jacqueline M. Ganser, Faicon Heights, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20110076336 | DRY POWDER PHARMACEUTICAL COMPOSITIONS FOR PULMONARY ADMINISTRATION, AND METHODS OF MANUFACTURING THEREOF - A method of making a dry powder pharmaceutical composition comprising: providing inactive ingredient particles; providing a micronized active ingredient; mixing the inactive ingredient particles with surface-modified nanoparticles to provide an inactive ingredient comprised of particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; and/or mixing the micronized active ingredient with surface-modified nanoparticles to provide a micronized active ingredient comprised of particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; and then mixing the micronized active ingredient with the inactive ingredient; the dry powder compositions made by the method; a use of said composition for the manufacture of a medicament for being delivered to the lungs of a mammal by administering a therapeutic amount of the dry powder pharmaceutical composition, and a dry powder inhalation device comprising a mouth piece, a powder containment system, and the dry powder pharmaceutical composition are disclosed. | 03-31-2011 |
Marco Ganser, Oberageri CH
| Patent application number | Description | Published |
|---|---|---|
| 20080210784 | Fuel Injection Valve - The housing body ( | 09-04-2008 |
| 20080296413 | Accumulator Injection System for an Internal Combustion Engine - Disclosed is a high-pressure accumulator injection system ( | 12-04-2008 |
| 20090065614 | FUEL INJECTION VALVE FOR INTERNAL COMBUSTION ENGINES - A control device ( | 03-12-2009 |
| 20100170476 | FUEL INJECTION DEVICE - The invention relates to an injection device for injecting high-pressure fuel into the combustion chamber of an internal combustion engine, said device comprising an injection valve assigned to a discrete reservoir chamber ( | 07-08-2010 |
| 20100294243 | FUEL INJECTION VALVE FOR INTERNAL COMBUSTION ENGINES - Disclosed is a fuel injection valve ( | 11-25-2010 |
Scott S. Ganser, Park City, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20090149431 | Eplerenone Drug Substance Having High Phase Purity - A novel crystalline form (Form L) of the aldosterone receptor antagonist drug eplerenone is provided having relatively high physical stability at normal temperatures of storage and use. Pharmaceutical compositions are also provided comprising Form L eplerenone, optionally accompanied by one or more other solid state forms of eplerenone, in a total unit dosage amount of eplerenone of about 10 to about 1000 mg, and further comprising one or more pharmaceutically acceptable excipients. Processes are provided for preparing Form L eplerenone and for preparing compositions comprising Form L eplerenone. A method for prophylaxis and/or treatment of an aldosterone-mediated condition or disorder is also provided, comprising administering to a subject a therapeutically effective amount of eplerenone, wherein at least a fraction of the eplerenone present is Form L eplerenone. | 06-11-2009 |
Scott Steven Ganser, O'Fallon, MO US
| Patent application number | Description | Published |
|---|---|---|
| 20090238820 | ANTI-MAdCAM ANTIBODY COMPOSITIONS - The present invention relates to anti-MAdCAM antibody compositions comprising a chelating agent, and methods of treating inflammatory disease in a subject. | 09-24-2009 |